Lv4
430 积分 2021-06-29 加入
POTENT AND SELECTIVE ORAL STAT6 DEGRADER KT-621 INHIBITS IL-4/IL-13 IN MOUSE MODELS OF ASTHMA
8天前
已完结
VV116 as a potential treatment for COVID-19
15天前
已完结
Intrinsic/proximal cell surface marker logic-gated extracellular targeted protein degradation in specific cell population
1个月前
已完结
Transforming TGF-β suppression into IL-15 stimulation: Advancing engineered CAR-T therapy for solid tumors
1个月前
已完结
A new roadmap for biopharmaceutical drug product development: Integrating development, validation, and quality by design
1个月前
已完结
Trends in the drug target landscape for autoimmune diseases
1个月前
已完结
Evaluation of Structural, Biological, and Functional Similarity of Biosimilar Granulocyte Colony Stimulating Factor to its Reference Product
2个月前
已完结
Analytical Comparison of the Originator Granulocyte-colony Stimulating Factor Filgrastim and its Biosimilars
2个月前
已完结
Chromatographic and electrophoretic assessment of Filgrastim biosimilars in pharmaceutical formulations
2个月前
已完结
The Design and Development of Pegfilgrastim (PEG-rmetHuG-CSF, Neulasta®)
2个月前
已完结
皖公网安备34019202002308
